Last update 08 May 2025

MUT x CACNA2D2 x CACNA2D1

Basic Info

Related Targets
MUTCACNA2D2CACNA2D1

Related

1
Drugs associated with MUT x CACNA2D2 x CACNA2D1
Gabapentin/B-complex
Target
CACNA2D1 x CACNA2D2 x MUT
Mechanism
CACNA2D1 blockers [+3]
Active Org.-
Originator Org.
Merck KGaA
Active Indication-
Inactive Indication-
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
2
Clinical Trials associated with MUT x CACNA2D2 x CACNA2D1
NCT01364298
/ CompletedPhase 4
Multicenter, Randomized, Open-label, Parallel Group, Phase IV Study to Compare the Efficacy and Safety of Gabapentin/B-complex Versus Pregabalin in the Management of Diabetic Peripheral Neuropathic Pain
NCT01263132
/ CompletedPhase 3
Neuropathic Pain Treatment Using F0434 vs. Gabapentin in Patients With Chronic Distal Diabetic Polyneuropathy: A Randomized, Controlled, Double-blind Study
100 Clinical Results associated with MUT x CACNA2D2 x CACNA2D1
Login to view more data
100 Translational Medicine associated with MUT x CACNA2D2 x CACNA2D1
Login to view more data
0 Patents (Medical) associated with MUT x CACNA2D2 x CACNA2D1
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free